Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Gastroenterology. 2023 Jun;164(7):1086–1106. doi: 10.1053/j.gastro.2023.03.214
Recommendation 7: In adults with CIC who do not respond to OTC agents, the panel suggests the use of lubiprostone over management without lubiprostone (conditional recommendation, low certainty of evidence).
Implementation considerations
  • Can be used as a replacement or as an adjunct to OTC agents.

  • Duration of treatment in trials was 4 weeks, but the drug label does not provide a limit.

  • Nausea may occur; however, the risk of nausea is dose-dependent and seems to be lower when taken with food and water.